These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2471945)

  • 1. Maternal serum alpha-fetoprotein (MSAFP) screening: the Keesler experience.
    Bombard AT; Rigdon DT; Flanagan JC
    Mil Med; 1989 Apr; 154(4):206-9. PubMed ID: 2471945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal oculocerebrorenal syndrome of Lowe associated with elevated maternal serum and amniotic fluid alpha-fetoprotein levels.
    Miller RC; Wolf EJ; Gould M; Macri CJ; Charnas LR
    Obstet Gynecol; 1994 Jul; 84(1):77-80. PubMed ID: 7516514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Maternal serum alpha-fetoprotein as a screening test for fetal Down syndrome].
    Bessho T; Kanazawa R; Shiotani T; Mitsuo M; Koyama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1995 Mar; 47(3):237-43. PubMed ID: 7535328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
    Schell DL; Drugan A; Brindley BA; Zador IE; Johnson MP; Schwartz DB; Evans MI
    J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of fetal chromosomal anomalies in patients with elevated maternal serum alpha-fetoprotein.
    Warner AA; Pettenati MJ; Burton BK
    Obstet Gynecol; 1990 Jan; 75(1):64-6. PubMed ID: 1688649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
    Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
    Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal diagnosis in diabetic gravidas: utility of ultrasound and maternal serum alpha-fetoprotein screening.
    Greene MF; Benacerraf BR
    Obstet Gynecol; 1991 Apr; 77(4):520-4. PubMed ID: 1706079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum alpha-fetoprotein screening and fetal chromosome anomalies: is lowering maternal age for amniocentesis preferable?
    Kaffe S; Hsu LY
    Am J Med Genet; 1992 Apr; 42(6):801-6. PubMed ID: 1372793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of maternal serum alpha-fetoprotein and ultrasound examination to screen fetal chromosomal abnormalities.
    Brizzi L; Cariati E; Periti E; Nannini R; Torricelli F; Cappelli G; Gheri G
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):85-8. PubMed ID: 2480431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical studies on maternal serum alpha-fetoprotein (MSAFP) of 532 cases--the median value, pregnancy outcomes and clinical evaluation].
    Hayashi M; Kohzu H
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct; 44(10):1211-8. PubMed ID: 1385554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MSAFP levels and oesophageal atresia.
    Chodirker BN; Chudley AE; MacDonald KM; Harman CR; Evans JA
    Prenat Diagn; 1994 Nov; 14(11):1086-9. PubMed ID: 7533286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal ascertainment of triploidy by maternal serum alpha-fetoprotein screening.
    Freeman SB; Priest JH; MacMahon WC; Fernhoff PM; Elsas LJ
    Prenat Diagn; 1989 May; 9(5):339-47. PubMed ID: 2471183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-fetoprotein.
    Drugan A; Dvorin E; Obrien JE; Johnson MP; Evans MI
    Curr Opin Obstet Gynecol; 1991 Apr; 3(2):230-4. PubMed ID: 1717020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-fetoprotein in obstetrics. Experience of a prenatal diagnosis center.
    Cariati E; Brizzi L; Periti E
    J Nucl Med Allied Sci; 1989; 33(3 Suppl):72-6. PubMed ID: 2480428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triploid partial molar pregnancy detected through maternal serum alpha-fetoprotein and HCG screening.
    Harper MA; Ruiz C; Pettenati MJ; Rao PN
    Obstet Gynecol; 1994 May; 83(5 Pt 2):844-6. PubMed ID: 7512706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum alpha-fetoprotein screening for neural tube defects. Report of a program with more than 30000 screened pregnancies.
    Candenas M; Villa R; Fernandez Collar R; Moina MJ; Pintado S; Garcia Saez F; Alvarez FV
    Acta Obstet Gynecol Scand; 1995 Apr; 74(4):266-9. PubMed ID: 7537429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin].
    Tanaka M; Natori M; Ishimoto H; Gohda N; Kiyokawa K; Yamauchi J; Miyazaki T; Kobayashi T; Nozawa S
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1229-33. PubMed ID: 7531210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of MSAFP screening on genetic services, 1984-1986.
    Greenberg F
    Am J Med Genet; 1988 Sep; 31(1):223-30. PubMed ID: 2464932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated maternal serum alpha-fetoprotein (MSAFP): interpretation and follow-up.
    Burton BK
    Clin Obstet Gynecol; 1988 Jun; 31(2):293-305. PubMed ID: 2456869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.